Glycosylation of Cancer Stem Cells: Function in Stemness, Tumorigenesis, and Metastasis
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (PO1 CA2117798, RO1 CA210637, RO1CA206444, RO1CA183459, R15GM088798, UO1 200466, P01CA217798, R01CA183459, R01CA210637, TMEN U54CA163120, EDRN UO1 CA200466, PCDC UO1 CA210240, SPORE P50CA127297, K22 CA175260)
- National Institutes of Health
- Elsa U Pardee Foundation-2013
- Nebraska Department of Health and Human Services (LB595)
This publication has 136 references indexed in Scilit:
- Two opposing roles of O-glycans in tumor metastasisTrends in Molecular Medicine, 2012
- O-GlcNAc signalling: implications for cancer cell biologyNature Reviews Cancer, 2011
- Inhibition of CD44 N- and O-linked glycosylation decreases endometrial cell lines attachment to peritoneal mesothelial cellsFertility and Sterility, 2011
- Core fucosylation is required for midline patterning during zebrafish developmentDevelopmental Dynamics, 2010
- MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progeniesCancer Letters, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cellsJournal of Molecular Medicine, 2008
- CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosisBritish Journal of Cancer, 2008
- EpCAM (CD326) finding its role in cancerBritish Journal of Cancer, 2007
- Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsivenessProceedings of the National Academy of Sciences, 2006